Pacey, Laura K.K.

Clustering autism: using neuroanatomical differences in 26 mouse models to gain insight into the heterogeneity

Ellegood, J., Anagnostou, E., Babineau, B. A., Crawley, J. N., Lin, L., Genestine, M., DiCicco-Bloom, E., Lai, J. K. Y., Foster, J. A., Peñagarikano, O., et al. (2015) · Molecular Psychiatry

Autism Spectrum Disorder ResearchGenetics and Neurodevelopmental Disorders

Cited by 288

Early developmental alterations in GABAergic protein expression in fragile X knockout mice

Adusei, D. C., Pacey, L. K. K., Chen, D., & Hampson, D. R. (2010) · Neuropharmacology

Genetics and Neurodevelopmental DisordersNeuroscience and Neuropharmacology Research

Cited by 139

Increased GABAB Receptor-Mediated Signaling Reduces the Susceptibility of Fragile X Knockout Mice to Audiogenic Seizures

Pacey, L. K. K., Heximer, S. P., & Hampson, D. R. (2009) · Molecular Pharmacology

Genetics and Neurodevelopmental DisordersEpilepsy research and treatment

Cited by 133

Developmental expression of FMRP in the astrocyte lineage: Implications for fragile X syndrome.

Pacey, L. K. K., & Doering, L. C. (2007) · Glia

Genetics and Neurodevelopmental DisordersNeurogenesis and neuroplasticity mechanisms

Cited by 128

Persistent astrocyte activation in the fragile X mouse cerebellum

Pacey, L. K. K., Guan, S., Tharmalingam, S., Thomsen, C., & Hampson, D. R. (2015) · Brain and Behavior

Genetics and Neurodevelopmental DisordersNeuroinflammation and Neurodegeneration Mechanisms

Cited by 39

The neurochemical basis for the treatment of autism spectrum disorders and Fragile X syndrome

Hampson, D. R., Adusei, D. C., & Pacey, L. K. K. (2011) · Biochemical Pharmacology

Genetics and Neurodevelopmental DisordersAutism Spectrum Disorder Research

Cited by 34